The Third Time is the Charm for Sanofi in its IPR Challenge of Immunex’s ʼ487 Patent February 27, 2019
Sandoz Files Declaratory Judgment of Non-Infringement For Filgrastim-Related Patent February 22, 2019
The PTAB Denies Institution of Two IPRs Involving a Patent Directed to the Treatment of Hemophilia B January 31, 2019
FDA Issues Guidance Documents on the “Deemed to be a License” Transition Provision of the BPCIA January 16, 2019
AbbVie Files Suit Against Sandoz Alleging Infringement of Two Humira®-Related Patents August 14, 2018
Genentech Files Suit Alleging Eli Lilly’s Taltz® Product Infringes a Newly Issued Genentech Patent July 16, 2018
Genentech Files Two New Lawsuits Against Celltrion Alleging Infringement of Patents Related to Rituxan® and Herceptin® July 12, 2018
Lilly Announces Positive Results for Galcanezumab in Treating Episodic Cluster Headaches May 25, 2018